BeiGene’s Brukinsa Among Nine Drugs To Win EU Marketing Thumbs Up

Tanezumab’s Modest Impact On Osteoarthritis Pain Draws Negative CHMP Opinion

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".